A Natural Path to Cognitive Enhancement with Somin-On™ Ashwagandha
Enhancing Memory and Cognitive Function with Somin-On™ Ashwagandha
Arjuna Natural introduces its innovative ashwagandha ingredient, designed to help maintain brain function in mature adults enduring mild cognitive challenges.
Understanding Somin-On™
Somin-On™ is the newest addition to Arjuna Natural's esteemed range of botanical formulations. What sets this particular ashwagandha product apart is its specific standardization to a 2% Sominone content, confirmed through HPLC. This formulation aims to enhance cognitive functions, specifically targeting attention and memory retention for individuals facing mild cognitive impairment (MCI).
Plant-Powered Cognitive Support
Benny Antony, PhD, Joint Managing Director of Arjuna Natural, emphasized the relevance of this new formulation, stating, "Our ashwagandha formula responds to the pressing concerns surrounding cognitive decline in the aging population. Many are searching for natural solutions to uphold mental clarity and stave off potential dementia as they grow older. Somin-On provides a promising, safe, and natural approach towards maintaining cognitive function and overall mental agility in older adults."
Mild cognitive impairment, while not severe enough to interrupt daily life, can alter memory and cognition noticeably. Research indicates that around 16% of individuals over 70 may experience some form of MCI. Alarmingly, studies show that nearly 50% of those diagnosed with MCI may develop Alzheimer's disease within five years, marking MCI as an early warning sign of potential dementia.
Addressing an Unmet Need
Dr. Antony highlighted the lack of approved treatments for MCI, stating, "Somin-On is our solution to bridge this gap and combat cognitive decline through natural means." This commitment to cognitive health has pushed Arjuna Natural to explore the potential benefits of Somin-On.
Conducted at the Hi-Tech Hospital and Trauma Center in Uttar Pradesh, India, a pivotal double-blind, placebo-controlled study led by Dr. Hari Prakash Rai enlisted 40 adults diagnosed with MCI. The participants were split into two groups: one receiving a daily dose of 250mg of Somin-On and the other a placebo, monitored over 60 days with evaluations at 30 and 60 days intervals.
Results from the Study
The findings were promising, indicating significant advancements across various cognitive function metrics in those consuming Somin-On versus those on placebo. Subjects reported improvements in immediate memory, general memory, and working memory according to the Wechsler Memory Scale-III (WMS-III). The Somin-On group also demonstrated significant enhancements in visuospatial processing from day 30 to day 60, as indicated by the Shepard Mental Rotation Test scores.
Further evaluations, including the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE), indicated noteworthy improvements in memory functions, including word recall, arithmetic abilities, language comprehension, and even basic motor skills. These results underscore Somin-On's potential role in augmenting attention, expediting information processing, and elevating overall cognitive prowess while reducing cognitive impairments.
The Science Behind Sominone
According to Dr. Antony, Sominone, derived from the Withania somnifera plant, is identified as the primary active component driving these benefits. Historically recognized as a notable Ayurvedic herb, ashwagandha has been utilized for centuries to mitigate stress and anxiety while promoting cognitive support. Sominone is recognized for its capability to enhance memory and cognitive functionalities.
Research demonstrates that Sominone can repair and rejuvenate nerve cells affected by amyloid-beta, a protein known to compromise brain connections. In animal studies, it has shown promise in enhancing neurite outgrowth and improving spatial memory, alongside bolstering nerve cell growth and repair, ultimately fostering cognitive enhancement.
In addition, this ashwagandha extract counteracts oxidative stress and mitochondrial dysfunction, showcasing its neuroprotective and anti-degenerative characteristics. Somin-On is presented as a sequel to Arjuna's acclaimed ashwagandha product, Shoden, which is standardized to 35% withanolide glycosides and supported by numerous clinical investigations aimed at alleviating stress, improving sleep quality, and overcoming anxiety.
About Arjuna Natural
Having established itself as a leader in India for over 25 years, Arjuna Natural specializes in standardized spice and botanical extracts for the food supplement industry. Founded in 1989, the company prioritizes eco-friendly and sustainable practices and serves clients across 70 nations. Its advanced research facility collaborates with international universities to innovate in phytochemistry, pharmacokinetics, formulation, and pre-clinical research. Arjuna's facilities meet the highest global standards for GMP certification while also obtaining ISO, NSF, Star-K kosher, and halal certifications.
Contact Information
For more details, reach out to Arjuna Natural Pvt. Ltd.
Benny Antony, PhD
Joint Managing Director
Website: www.arjunanatural.com
Twitter: @ArjunaExtracts
Frequently Asked Questions
What is Somin-On™ Ashwagandha?
Somin-On™ is an advanced ashwagandha extract formulated to enhance cognitive functions such as memory and attention.
Who can benefit from Somin-On™?
This product is aimed at adults experiencing mild cognitive impairment wishing to maintain better memory and cognitive function.
How does Somin-On™ work?
Somin-On™ contains Sominone, an active component that enhances nerve repair and supports cognitive function through its neuroprotective properties.
What does the clinical study reveal?
The clinical trial demonstrated significant improvements in memory, cognitive performance, and overall brain function among participants using Somin-On™.
What makes Arjuna Natural a trusted name?
Arjuna Natural has over 25 years in the industry, renowned for eco-friendly practices and high-quality botanical extracts, certified at global standards.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.